Commercial Value Realization for Pharma & Life Sciences.
New Title
Breakthrough Science That Never Reaches a Patient Might as Well Not Exist.
In Some Therapeutic Areas, Up to 50% of Written Scripts Never Become Initiated Therapy.
Together , We’ll Make Sure More of Them Do.
The Shift
Consumer-Grade Isn't an Ideology.
It's a Commercial Imperative.
Healthcare professionals are also high expectation consumers in their "Other Life."
The global pharma industry must face an irrefutable truth: HCPs are consumers too. Trained by brand experiences with leading consumer brands in their everyday lives, they bring those same expectations of ease, relevance, and simplicity into their professional lives.
Prescribing decisions are increasingly shaped by experiential attributes.
35% of prescribing decisions are now shaped by HCPs’ experiences with pharma (DT Consulting), yet 62% feel overwhelmed by pharma engagement (Indegene). Like 74% of consumers, how likely are they to leave a brand after three or fewer negative experiences? (Salesforce).
Experience now drives whether value is fully realized as patient and commercial impact.
It governs how prescribing intent progresses across access, fulfillment, and adherence, shaping the ease and continuity of the journey, and ultimately determining whether intent becomes patient outcomes and realized commercial value, or is lost to friction and fragmentation.
The Structural Gap
Pharma Doesn't Have a Demand Problem.
It Has a Systemic Value Leakage Problem.
Pharma Built the Intent Engine. It Never Built the Value Realization System.
Pharma has engineered the front-end with extraordinary rigor: segmentation, targeting, CRM, incentives, access strategy, and now AI. But after the script is written, the system fragments. Field, access, specialty pharmacy, patient services, reimbursement, and medical teams operate across disconnected data and different definitions of success as HCPs and patients need journey progression most
Consumer-Grade Has Exposed a Structural Gap in the Commercial System.
The Consumer-Grade standard is driving systemic value leakage, degrading both patient outcomes and commercial performance. Brand investment creates demand. Field and omnichannel execution win interactions. Then the value quietly leaks away at the handoffs, the unmeasured moments, the points of friction, administrative burden and the resolution loops that never close.
This Has Created a Multi-Billion Dollar Blindspot in Pharma Companies.
Pharma’s blindspot begins after the script is earned. The financial hit is massive, but the visibility is minimal. Investment has already been made to generate demand and win intent. But when patients do not start, stay, and benefit, that clinical and commercial value is never fully realized. It becomes hidden financial exposure and invisible as a connected risk.
The commercial question, and the C-suite imperative, is no longer whether pharma can create intent. It is whether the organization can see, own, and convert that intent into realized value.
The Commercial System Wasn't Built for This.
Customer Excellence Is.
Here's the Formula.
Solving the Systemic Value Leakage Problem
Doesn't Happen By Accident. It Has a Formula.
Value Realization =
(Brand×Product×Experience)Cultureⁿ× (1−CVaR)
(Brand: the equity. Product: the asset. Experience: the differentiator. Culture: the compounding force. Customer Value at Risk: the drag)
Challenges We Solve
Three Questions. Three Moves.
How the Formula Gets Operational.
The formula doesn't activate the same way for a brand leader trying to recover yield, a field leader trying to systematize intelligence, or an enterprise leader trying to embed operating discipline. But all three are solving the same structural problem: the gap between demand creation and value realization. Pick your entry point. Solve your challenge. The system compounds from there.
Accelerate Brand
Growth.
Scripts are strong. Revenue has stalled. How do we reaccelerate growth?
Identify where brand demand is failing to become patient progression. Quantify the leakage. Remove the barriers. Recover the growth
Strengthen Field
Performance
Our field sees the barriers. Why isn't that intelligence turning into action?"
Position your field organization as a barrier-detection and removal engine. Convert field intelligence into activation. Drive consistent patient progression.
Embed Enterprise
Value Realization
Billions in tech and AI investments. Why no proportional return?
Embed value realization thinking into how your commercial organization thinks, decides, and operates. Make customer excellence structural, not aspirational.
Featured Resource Download
Pharma’s Hidden
Intent-to-Impact Gap
Breakthrough science only creates impact when patients can start, stay, and benefit. But most pharma organizations leak value where commercial strategy meets ground reality.
Discover why field effectiveness is the essential lever, and how AI-powered journey operations close the intent-to-impact gap.
Download the White Paper
Track Record Snapshot
Integrating The Formula Into the
Commercial System Delivers Real Results.
Brand Launch Recovery
12% NBRx Brand
Growth Turnaround
Stalled high-priority launch restored to growth
trajectory without added promotional intensity.
Field Force Rewired
Field-led 30+% Brand
Revenue Uplift
Frontline and HCP experiential feedbck operationalized into enterprise field force ways of working.
Omnichannel Activation
100+ Markets Rewired
with VoC Signals
Signal-driven commercial improvements implemented across digital, field, and DTC channels.
Media Mentions
Featured in Media Conversations on Customer Excellence and Commercial Transformation in Pharma.
Pfizer Has a New Playbook for Reviving Sales—and It’s Starting to Pay Off.
Drugmaker has revamped how it packages, promotes, and sells certain medicines in bid to overcome post-pandemic slump.
By Jared S. Hopkins
How Pfizer Is Building Customer Experience From the Inside Out.
An exclusive interview with Pfizer’s Wayne Simmons on reshaping customer experience by listening to those interacting with healthcare professionals.
By Dom Nicastro
The Book
Practiced. Proven. Published. Codifying the Commercial Discipline of Customer Excellence.
Customer Excellence did not exist as a defined body of work. I partnered with a fellow founding faculty member of the master's program in Customer Experience Management at Michigan State University to codify it. Wiley published the result. The Customer Excellence Enterprise is a structural and systemic approach to embedding customer centricity and customer experience into the enterprise itself, designed to close the gap between intent and impact in a consumer-grade world. Now adopted in graduate programs and enterprise capability programs.
